No Difference in Radiologic Outcomes With Extended-Interval Natalizumab Dosing Compared With Standard Dosing
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders